Metabolic aspects of different phenotypes of polycystic ovary syndrome: Iranian PCOS Prevalence Study
- 16 January 2014
- journal article
- research article
- Published by Wiley in Clinical Endocrinology
- Vol. 81 (1) , 93-99
Abstract
Summary: Objective: To compare insulin resistance (IR) and metabolic characteristics of different phenotypes of polycystic ovary syndrome (PCOS) and healthy controls in a representative sample of reproductive‐aged Iranian women.Design: Cross‐sectional community‐based study.Patients: Of 915 participants, 136 met Rotterdam criteria for PCOS and were divided in four subgroups: ovulatory dysfunction with polycystic ovaries (Anovu + PCO), hyperandrogenism with PCO (HA + PCO), hyperandrogenism with ovulatory dysfunction (HA + Anovu) and full Rotterdam (HA + Anovu + PCO). Also 423 subjects served as normal controls, and the rest of participants were analysed as isolated HA, Anovu or PCO subgroups.Measurements: Anthropometric measures, biochemical parameters and IR were compared between different groups. IR was defined using the homeostatic model assessment‐IR (HOMA‐IR).Results: Overall prevalence of IR in PCOS and normal women were 26·5% and 23·9%, respectively (P = 0·03). After age and BMI adjustment, there was no difference regarding metabolic characteristics between different PCOS phenotypes. Also metabolic characteristics, fasting insulin and HOMA‐IR were comparable in PCOS subjects with hyperandrogenism and the nonhyperandrogenic phenotype (Anovu + PCO). In regression analysis, only overweight and obesity (BMI ≥ 25 kg/m2) had an independent association with IR (OR: 2·49, CI: 1·06–5·82, P = 0·03).Conclusions: In a representative sample of an Iranian PCOS population, there is no significant difference between different PCOS phenotypes or between PCOS women and normal subjects regarding their metabolic characteristics. These findings suggest that overall metabolic screening may not always be required for all women diagnosed with PCOS. Larger‐scale population‐based studies are needed to further assess these issues.Keywords
This publication has 32 references indexed in Scilit:
- The Different Phenotypes of Polycystic Ovary Syndrome: No Advantages for Identifying Women with Aggravated Insulin Resistance or Impaired LipidsExperimental and Clinical Endocrinology & Diabetes, 2011
- The prevalence of polycystic ovary syndrome in a community sample of Iranian population: Iranian PCOS prevalence studyReproductive Biology and Endocrinology, 2011
- The Polycystic Ovary Post-Rotterdam: A Common, Age-Dependent Finding in Ovulatory Women without Metabolic SignificanceThe Journal of Clinical Endocrinology & Metabolism, 2010
- The insulin-resistant phenotype of polycystic ovary syndromeFertility and Sterility, 2010
- Type 2 diabetes and cardiovascular disease in polycystic ovary syndrome: what are the risks and can they be reduced?Diabetic Medicine, 2010
- Characteristics of different phenotypes of polycystic ovary syndrome based on the Rotterdam criteria in a large‐scale Chinese populationBJOG: An International Journal of Obstetrics & Gynaecology, 2009
- Risk of metabolic complications in the new PCOS phenotypes based on the Rotterdam criteriaFertility and Sterility, 2007
- Unravelling the phenotypic map of polycystic ovary syndrome (PCOS): a prospective study of 634 women with PCOSClinical Endocrinology, 2007
- Metabolic characteristics of women with polycystic ovaries and oligo‐amenorrhoea but normal androgen levels: implications for the management of polycystic ovary syndromeClinical Endocrinology, 2007
- Characteristics of different phenotypes of polycystic ovary syndrome in a Bulgarian populationGynecological Endocrinology, 2007